Brown Brothers Harriman & CO Neogenomics Inc Transaction History

Brown Brothers Harriman & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $5,391 - $8,856	686 Added 207.25%	1,017 $9,000
Q2 2022 Aug 11, 2022	BUY	$7.06 - $13.97 $2,336 - $4,624	331 New	331 $3,000
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $5,253 - $6,731	-217 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $9,061 - $15,262	-442 Reduced 67.07%	217 $6,000
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $12,600 - $17,292	659 New	659 $13,000

282

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.56B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.